Trial Profile
Randomized Controlled Study of Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Betamethasone
- Indications Hepatitis C
- Focus Therapeutic Use
- 02 Jun 2015 New trial record